These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 26765648)
1. Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Hashmi S; Ahmed M; Murad MH; Litzow MR; Adams RH; Ball LM; Prasad VK; Kebriaei P; Ringden O Lancet Haematol; 2016 Jan; 3(1):e45-52. PubMed ID: 26765648 [TBL] [Abstract][Full Text] [Related]
2. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature. Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Chen X; Wang C; Yin J; Xu J; Wei J; Zhang Y PLoS One; 2015; 10(8):e0136991. PubMed ID: 26323092 [TBL] [Abstract][Full Text] [Related]
4. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Zhao L; Chen S; Yang P; Cao H; Li L Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis. Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease. Döring M; Cabanillas Stanchi KM; Lenglinger K; Treuner C; Gieseke F; Erbacher A; Mezger M; Vaegler M; Schlegel PG; Greil J; Bettoni da Cunha Riehm C; Faul C; Schumm M; Lang P; Handgretinger R; Müller I Stem Cells Dev; 2021 Mar; 30(5):234-246. PubMed ID: 33446053 [TBL] [Abstract][Full Text] [Related]
8. [Mesenchymal stem cells for treatment of graft-versus-host disease]. Najima Y Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881 [TBL] [Abstract][Full Text] [Related]
9. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial. Fu H; Sun X; Lin R; Wang Y; Xuan L; Yao H; Zhang Y; Mo X; Lv M; Zheng F; Kong J; Wang F; Yan C; Han T; Chen H; Chen Y; Tang F; Sun Y; Chen Y; Xu L; Liu K; Zhang X; Liu Q; Huang X; Zhang X BMC Med; 2024 Feb; 22(1):85. PubMed ID: 38413930 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome. von Dalowski F; Kramer M; Wermke M; Wehner R; Röllig C; Alakel N; Stölzel F; Parmentier S; Sockel K; Krech M; Schmitz M; Platzbecker U; Schetelig J; Bornhäuser M; von Bonin M Stem Cells; 2016 Feb; 34(2):357-66. PubMed ID: 26418955 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease. Ringdén O; Gustafsson B; Sadeghi B Front Immunol; 2020; 11():567210. PubMed ID: 33193339 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence. Rizk M; Monaghan M; Shorr R; Kekre N; Bredeson CN; Allan DS Biol Blood Marrow Transplant; 2016 Aug; 22(8):1416-1423. PubMed ID: 27130504 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Le Blanc K; Frassoni F; Ball L; Locatelli F; Roelofs H; Lewis I; Lanino E; Sundberg B; Bernardo ME; Remberger M; Dini G; Egeler RM; Bacigalupo A; Fibbe W; Ringdén O; Lancet; 2008 May; 371(9624):1579-86. PubMed ID: 18468541 [TBL] [Abstract][Full Text] [Related]
15. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease. Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533 [TBL] [Abstract][Full Text] [Related]